Covid-19 vaccines roughly halved the chances that a US adult would need to visit the emergency room or be hospitalized with their infections last fall and winter, according to two sources familiar ...

After the rofecoxib (Vioxx) withdrawal in 2004 made painfully clear how much harm a passive reporting system can miss, ...

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, ...

Please provide your email address to receive an email when new articles are posted on . A real-world study examined the effectiveness of the 2024-2025 vaccines among children U.S. The vaccines were 76 ...

Earlier this year researchers from Drexel’s Urban Health Collaborative launched the COVID-19 Health Inequities in Cities dashboard. As of last month, the dashboard has undergone several updates ...

Health experts say hantavirus is unlikely to become “the next COVID” because its transmission patterns are very different and ...

WASHINGTON — The U.S. will likely begin distributing a third vaccine against COVID-19 in the next week, and health officials are girding for questions about which one is best. The Johnson & Johnson ...

Shionogi & Co. looks set to put its COVID-19 vaccine into practical use by the end of March 2022 following a government ...